scispace - formally typeset
D

Dong-Kwon Rhee

Researcher at Sungkyunkwan University

Publications -  120
Citations -  3119

Dong-Kwon Rhee is an academic researcher from Sungkyunkwan University. The author has contributed to research in topics: Ginseng & Streptococcus pneumoniae. The author has an hindex of 28, co-authored 115 publications receiving 2705 citations. Previous affiliations of Dong-Kwon Rhee include Kigali Institute of Science and Technology.

Papers
More filters
Journal ArticleDOI

Immunostimulating effects of acidic polysaccharides extract of panax ginseng on macrophage function

TL;DR: Results suggest that ginsan has an immunopotentiating effects on macrophages and these abilities could be used clinically for the treatment of diseases such as cancer.
Journal ArticleDOI

Reversal of p-glycoprotein-mediated multidrug resistance by ginsenoside rg (3)

TL;DR: In vitro and in vivo modulations of MDR by ginsenoside Rg(3), a red ginseng saponin, were investigated and showed that inhibition of drug efflux by Rg (3) was due to neither repression of M DR1 gene expression nor Pgp level.
Journal ArticleDOI

Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA.

TL;DR: Allicin induces a caspase-independent apoptotic pathway mediated by mitochondrial release of AIF and PKA appears to be involved in allicin-induced apoptosis in gastric epithelial cells.
Journal ArticleDOI

Effect of Heat Shock and Mutations in ClpL and ClpP on Virulence Gene Expression in Streptococcus pneumoniae

TL;DR: Interestingly, immunoblot and real-time reverse transcription-PCR analysis demonstrated that pneumolysin and pneumococcal surface antigen A were induced by heat shock in wild-type S. pneumoniae.
Journal ArticleDOI

The ClpP Protease of Streptococcus pneumoniae Modulates Virulence Gene Expression and Protects against Fatal Pneumococcal Challenge

TL;DR: Fractionation studies demonstrated that ClpP was translocated into the cell wall after heat shock, and immunization of mice withClpP elicited a protective immune response against fatal systemic challenge with S. pneumoniae D39, making ClPP a potential vaccine candidate for pneumococcal disease.